N-PORT filing recap · July 2024
What did First Eagle Global Fund buy in July 2024?
Reported stock-position changes between this filing and the previous one. These are First Eagle Global Fund's own holdings, not the firm's.
Stock value
$26.46B
Positions
61
Estimated turnover
6.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
First Eagle Global Fund opened new positions in Bio-Rad Laboratories, UnitedHealth Group, and Charter Communications, while exiting Walmart entirely. The fund added to Slb, Philip Morris International, Elevance Health, Nov, Ambev, Ipg Photonics, and Expeditors International of Washington. It trimmed Colgate-Palmolive and Ugi Corporation, substantially reduced Taiwan Semiconductor Manufacturing, and substantially increased Salesforce, Becton Dickinson, and Dentsply Sirona.